CCO slides from Martin Abrahamson, MD, and Anne Peters, MD, on GLP-1 RAs to address elevated A1C, obesity, and CV risk, plus strategies to improve tolerability, adherence
Slides from CCO and John Russell, MD, on GLP-1 RAs to address elevated A1C, obesity, and CV risk, plus strategies to improve tolerability, adherence
CME: Type 2 diabetes management: Dr. Veronica K. Piziak on NPH, regular insulin, switching to avoid hypoglycemia/reduce CV risk in T2DM
Dr. Kenneth Cusi summarizes some of the most important data from recent studies in patients at high risk for NASH/NAFLD.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.